|
NUP62 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.451400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.463000E-01 |
| Normal-vs-Stage2 |
3.666400E-01 |
| Normal-vs-Stage3 |
2.114200E-01 |
| Normal-vs-Stage4 |
2.494200E-01 |
| Stage1-vs-Stage2 |
3.177600E-02 |
| Stage1-vs-Stage3 |
8.189200E-01 |
| Stage1-vs-Stage4 |
9.113800E-01 |
| Stage2-vs-Stage3 |
5.938300E-02 |
| Stage2-vs-Stage4 |
6.682400E-02 |
| Stage3-vs-Stage4 |
9.457400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.361700E-02 |
| Normal-vs-AfricanAmerican |
1.820970E-01 |
| Normal-vs-Asian |
3.245900E-02 |
| Caucasian-vs-AfricanAmerican |
7.824600E-01 |
| Caucasian-vs-Asian |
2.563000E-01 |
| AfricanAmerican-vs-Asian |
6.066600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.448800E-01 |
| Normal-vs-Female |
2.218400E-01 |
| Male-vs-Female |
6.927400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.499620E-01 |
| Normal-vs-Age(41-60Yrs) |
2.504000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.960600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.523800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.620400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.275700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.260200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.717980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.660800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.376600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.973800E-01 |
| Classical-VS-Follicular |
1.26565424807268E-14 |
| Classical-VS-Other |
2.211400E-01 |
| Classical-VS-Normal |
1.103670E-02 |
| Tall-VS-Follicular |
2.69470000002769E-06 |
| Tall-VS-Other |
2.320400E-01 |
| Tall-VS-Normal |
3.968300E-02 |
| Follicular-VS-Other |
1.979210E-01 |
| Follicular-VS-Normal |
9.361900E-04 |
| Other-VS-Normal |
8.456200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.003000E-01 |
| Normal-vs-N1 |
9.743400E-01 |
| N0-vs-N1 |
7.308000E-01 |
|
|
